Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Multiple Sclerosis
Clinical trial register · Canada

Multiple Sclerosis Trials in Canada, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Canada and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6567 matching records held by the registry are in this view. Synced 13 Nov 2026, 03:20 UTC
6567
Studies in scope
all four open statuses
3491
Recruiting now
open to new participants
883
Lead sponsors
across recruiting studies
Top sites
Montreal 7 Calgary 7 Ottawa 7 Gatineau 5 Toronto 5

Multiple Sclerosis trials in Canada

23 of 6567 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Canada
Start
Not yet open
University of Melbourne
Not applicable
240
Toronto
2026-11-01
Not yet open
Transcranial Magnetic Stimulation for Depression in Multiple Sclerosis
NCT07562074Multiple Sclerosis, Depression - Major Depressive Disorder, Fatigue
University of Calgary
Phase 1
20
Calgary
2026-06-15
Recruiting
Study of KITE-363 in Participants With Autoimmune Neurologic Diseases That Did Not Respond to Usual Treatment
NCT07304154Chronic Inflammatory Demyelinating Polyneuropathy, Myasthenia Gravis, Multiple Sclerosis
Kite, A Gilead Company
Phase 1
57
Montreal, Ottawa
2026-04-10
Recruiting
Innovative Approaches to Enhance Balance and Neuroplasticity in Multiple Sclerosis
NCT07174973Multiple Sclerosis, Mobility Limitation, Balance; Distorted, Gait
University Health Network, Toronto
Not applicable
24
Toronto
2025-12-30
Recruiting
AstraZeneca
Phase 1
24
Montreal
2025-12-09
Recruiting
University of Calgary
Phase 2
30
Calgary
2025-12-05
Recruiting
Clinique Neuro-Outaouais
Not applicable
70
Gatineau
2025-10-15
Not yet open
Robert Simpson
Not applicable
120
Toronto
2025-01-01
Recruiting
McMaster University
Not applicable
46
Hamilton
2024-10-01
Not yet open
Remote Ischemic Conditioning in PPMS
NCT06171334Multiple Sclerosis
University of Calgary
Not applicable
45
Calgary
2024-07-01
Recruiting
Implementation of an App-based Walking Aid Skills Training Program
NCT05347875Lower Limb; Sprain (Strain), Lower Limb Fracture, Stroke, Multiple Sclerosis
University of Calgary
Not applicable
52
Calgary, Québec
2024-06-01
Active, closed
Sanofi
Phase 3
943
Calgary, Burnaby, Vancouver, Moncton, London, Ottawa, Toronto, Gatineau
2023-12-27
Active, closed
Sanofi
Phase 3
1,655
Edmonton, St. John's, London, Ottawa, Gatineau, Granby, Lévis, Québec
2023-12-13
Active, closed
Ad scientiam
Not applicable
336
Burnaby, Ottawa, Toronto, Vancouver
2023-09-22
Active, closed
Celestra Health Systems
Observational
90
Ottawa
2023-07-01
Recruiting
Centre hospitalier de l'Université de Montréal (CHUM)
Phase 2
250
Montreal
2022-11-10
Active, closed
Hoffmann-La Roche
Phase 3
1,300
Calgary, Edmonton, Vancouver, Ottawa, Gatineau, Greenfield Park, Montreal
2022-05-03
Recruiting
Innodem Neurosciences
Observational
168
Montreal
2021-10-18
Active, closed
Sanofi
Phase 2
129
Gatineau
2021-06-07
Active, closed
Hoffmann-La Roche
Phase 3
864
Greenfield Park, Lévis
2020-11-26
Active, closed
Novartis Pharmaceuticals
Phase 3
240
Calgary, Ottawa
2013-07-26
Rows per page Showing 1–23 of 23
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Canadian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 November 2026. https://priyalifescience.com/clinical-trials-canada/condition/multiple-sclerosis

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Canada and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,567 studies in total at the last sync on 13 Nov 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 23 of those studies listing the condition Multiple Sclerosis.

How many Multiple Sclerosis trials are recruiting in Canada?

9 of the 23 studies on this page are recruiting new participants as of the 13 Nov 2026, 03:20 UTC sync. A further 4 have not yet opened recruitment, 10 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Multiple Sclerosis), 23 studies
PhaseStudiesRecruitingShare
Not applicable8434.8%
Phase 36026.1%
Phase 14217.4%
Phase 23213%
Observational218.7%

Most active sponsors

Lead sponsors with the most studies (Multiple Sclerosis)
Lead sponsorStudiesRecruiting
Hoffmann-La Roche40
University of Calgary42
Sanofi30
Ad scientiam10
AstraZeneca11
Celestra Health Systems10
Centre hospitalier de l'Université de Montréal (CHUM)11
Clinique Neuro-Outaouais11
Innodem Neurosciences11
Kite, A Gilead Company11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.